Previous Article | Next Article ![]()
Infection and Immunity, May 2000, p. 2992-2994, Vol. 68, No. 5
Department of
Otorhinolaryngology1 and Center for
Electronmicroscopy,2 Leiden University
Medical Center, Leiden, The Netherlands
Received 7 September 1999/Returned for modification 15 November
1999/Accepted 27 January 2000
In this study, the efficacy of bactericidal/permeability-increasing
protein (BPI) was assessed in a rat model of chronic otitis media with
effusion. BPI injection prevented disturbance of the mucociliary
clearance system of the middle ear. Hence, it is postulated that BPI
can be a new therapy for chronic otitis media with effusion.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Bactericidal/Permeability-Increasing Protein
Prevents Mucosal Damage in an Experimental Rat Model of Chronic
Otitis Media with Effusion
*
Corresponding author. Mailing address: Dept. of
Otorhinolaryngology (Room J2-60), Leiden University Medical Center,
P.O. Box 9600, NL-2300 RC, Leiden, The Netherlands. Phone: 031 71 526 2439. Fax: 031 71 524 8201. E-mail: M.J.Nell{at}lumc.nl.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»